MAPT and Alzheimer disease: Our previous study showed that therapeutic anti-tau antibody DC8E8 recognizes pathological tau proteins in human AD brains, discriminates between diseased and healthy tau proteins, reduces formation of insoluble oligomerized tau and mature neurofibrillary tangles in a murine tauopathy model [23].